Montelukast as a controller of atopic syndrome.
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2013
At a glance
- Drugs Montelukast (Primary)
- Indications Allergic asthma; Allergic conjunctivitis; Allergic rhinitis; Hypersensitivity; Urticaria
- Focus Therapeutic Use
- Acronyms MONTAS
- 07 Jun 2017 Biomarkers information updated
- 14 Sep 2013 Last checked against European Clinical Trials Database.
- 27 Nov 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History